Oklahoma 2022 2022 Regular Session

Oklahoma House Bill HB2660 Amended / Bill

Filed 03/01/2021

                     
 
HB2660 HFLR 	Page 1 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
HOUSE OF REPRESENTATIVES - FLOOR VERSION 
 
STATE OF OKLAHOMA 
 
1st Session of the 58th Legislature (2021) 
 
COMMITTEE SUBSTITUTE 
FOR 
HOUSE BILL NO. 2660 	By: Echols 
 
 
 
 
 
COMMITTEE SUBSTITUTE 
 
An Act relating to medical marijuana; amending 
Section 4, State Question No. 788, Initiative 
Petition No. 412 (63 O.S. Supp. 2020, Section 423), 
which relates to medical marijuana processor 
licensing requirements; providing for the issuance of 
volatile and nonvolatile processor licenses; updating 
language; amending Section 17, Chapter 11, O.S.L. 
2019, as amended by Section 4, Chapter 312, O.S.L. 
2019 (63 O.S. Supp. 2020, Section 427.17), which 
relates to the Oklahoma Medical Marijuana and Patient 
Protection Act; modifying test batch requirements for 
licensed medical marijuana commercial growers and 
processors; defining certain term; and providing an 
effective date. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     Section 4, State Question No. 788, 
Initiative Petition No. 412 (63 O.S. Supp. 2020, Section 423), is 
amended to read as follows: 
Section 423.  A.  The Oklahoma State Department of Health shall 
within thirty (30) days of passage of this initiative, make 
available, on their its website, in an easy-to-find location, an   
 
HB2660 HFLR 	Page 2 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
application for a medical marijuana processing processor license.  
The Department shall be authorized to issue two types of medical 
marijuana processor licenses: 
1.  Nonvolatile, which involves using any solvent in the 
extraction process that is not a volatile solvent, including carbon 
dioxide; and 
2.  Volatile, which involves using any solvent that is or 
produces a flammable gas or vapor that, when present in the air in 
sufficient quantities, will create explosive or ignitable mixtures 
and may also include extraction using nonvolatile solvents or no 
solvents. 
The application fee for a nonvolatile or volatile medical marijuana 
processor license shall be Two Thousand Five Hundred Dollars 
($2,500.00) and methods.  Methods of payment will shall be provided 
on the website.  The Oklahoma State Department of Health shall have 
two (2) weeks to review the application, approve or reject the 
application, and mail the approval/rejection letter (if rejected, 
stating reasons for rejection) to the appli cant. 
B.  The Oklahoma State Department of Health must shall approve 
all applications which meet the following criteria: 
1.  Applicant must be age twenty -five (25) or older; 
2.  Any applicant, applying as an individual, must show 
residency in the State of Oklahoma;   
 
HB2660 HFLR 	Page 3 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  All applying entities must show that all members, managers, 
and board members are Oklahoma residents; 
4.  An applying entity may show ownership of non -Oklahoma 
residents, but that percentage ownership may not exceed twenty -five 
percent (25%); 
5.  All applying individuals or entities must be registered to 
conduct business in the State of Oklahoma; and 
6.  All applicants must disclose all ownership ;. 
7.  Applicant(s) An applicant with only a nonviolent felony 
conviction(s) in the last two (2) ye ars, or any other felony 
conviction in five (5) years, inmates, or any person currently 
incarcerated may not qualify for a medical marijuana processing 
processor license. 
C.  A licensed medical marijuana processor may take marijuana 
plants and distill or p rocess these plants into concentrates, 
edibles, and other forms for consumption.  As required by subsection 
D of this section, the Oklahoma State Department of Health will 
shall, within sixty (60) days of passage of this initiative, make 
available a set of standards which will be used by licensed medical 
marijuana processors in the preparation of edible marijuana 
products.  This should be in line with current food preparation 
guidelines and no excessive or punitive rules may be established by 
the Oklahoma State Department of Health.  Once a year, the Oklahoma 
State Department of Health may inspect a processing operation and   
 
HB2660 HFLR 	Page 4 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
determine its compliance with the preparation standards.  If 
deficiencies are found, a written report of deficiency will the 
deficiencies shall be issued to the licensed medical marijuana 
processor.  The licensed medical marijuana processor will shall have 
one (1) month to correct the deficiency or be subject to a fine of 
Five Hundred Dollars ($500.00) for each deficiency.  A licensed 
medical marijuana processor may sell marijuana products it creates 
to a licensed retailer, or any other licensed medical marijuana 
processor.  Further, these sales will shall be considered wholesale 
sales and not subject to taxation.  Under no circumstances ma y a 
licensed medical marijuana processor sell marijuana, or any 
marijuana product, directly to a medical marijuana license holder 
patient licensee or caregiver licensee .  However, a licensed medical 
marijuana processor may process cannabis into a concentra ted form, 
for a medical license holder, marijuana patient licensee for a fee.  
Processors will Licensed medical marijuana processors shall be 
required to complete a monthly yield and sales report to the 
Oklahoma State Department of Health.  This report will be due on the 
15th fifteenth of each month and provide reporting on the previous 
month.  This report will shall detail the amount of marijuana 
purchased in pounds, the amount of marijuana cooked or processed in 
pounds, and the amount of waste in pounds. Additionally, this 
report will shall show total wholesale sales in dollars.  The 
Oklahoma State Department of Health will shall have oversight and   
 
HB2660 HFLR 	Page 5 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
auditing responsibilities to ensure that all marijuana being grown 
is accounted for.  A licensed medical marijuana processor will shall 
only be subject to a penalty if a gross discrepancy exists and 
cannot be explained.  Penalties for fraudulent reporting occurring 
within any 2 year two-year time period will shall be an initial fine 
of Five Thousand Dollars ($5, 000.00) (first) for a first offense and 
revocation of licensing (second) the medial marijuana processor 
license for a second offense . 
D.  The Department shall oversee inspection and compliance of 
licensed medical marijuana processors producing products wit h 
marijuana as an additive.  The Oklahoma State Department of Health 
will shall be compelled to, within thirty (30) days of passage of 
this initiative, appoint a board of twelve (12) Oklahoma residents, 
who are marijuana industry experts, to create a list of food safety 
standards for processing and handling medical marijuana in Oklahoma.  
These standards will shall be adopted by the agency Department and 
the agency Department can enforce these standards for licensed 
medical marijuana processors.  The agency will Department shall 
develop a standards review procedure and these standards can may be 
altered by calling another board of twelve (12) Oklahoma marijuana 
industry experts.  A signed letter of twenty (20) operating licensed 
medical marijuana processors would constitute a need for a new board 
and standard standards review.   
 
HB2660 HFLR 	Page 6 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
E.  If it becomes permissible , under federal law, marijuana may 
be moved across state lines. 
F.  Any device used for the consumption of medical marijuana 
shall be considered legal to be sold, manufactured, distributed, and 
possessed.  No merchant, wholesaler, manufacturer, or individual may 
unduly be harassed or prosecuted for selling, manufacturing, or 
possession of medical marijuana paraphernalia. 
SECTION 2.     AMENDATORY     Section 17, Chapter 11, O.S.L. 
2019, as amended by Section 4, Chapter 312, O.S.L. 2019 (63 O.S. 
Supp. 2020, Section 427.17), is amended to read as follows: 
Section 427.17  A.  There is hereby created a medical marijuana 
testing laboratory license as a category of the medical marijuana 
business license.  The Authority is hereby enabled to monitor, 
inspect and audit a licensed testing laboratory under this act. 
B.  The Authority is hereby authorized to contract with a 
private laboratory for the purp ose of conducting compliance testing 
of medical marijuana testing laboratories licensed in this state.  
Any such laboratory under contract for compliance testing shall be 
prohibited from conducting any other commercial medical marijuana 
testing in this state. 
C.  The Authority shall have the authority to develop acceptable 
testing and research practices, including but not limited to 
testing, standards, quality control analysis, equipment 
certification and calibration, and chemical identification and   
 
HB2660 HFLR 	Page 7 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
substances used in bona fide research methods so long as it complies 
with this act. 
D.  A person who is a direct beneficial owner or an indirect 
beneficial owner of a medical marijuana dispensary, medical 
marijuana commercial grower, or medical marijuana processo r shall 
not be an owner of a laboratory. 
E.  A laboratory and a laboratory applicant shall comply with 
all applicable local ordinances, including but not limited to 
zoning, occupancy, licensing and building codes. 
F.  A separate license shall be required f or each specific 
laboratory. 
G.  A medical marijuana testing laboratory license may be issued 
to a person who performs testing and research on medical marijuana 
and medical marijuana products for medical marijuana businesses, 
medical marijuana research fac ilities, medical marijuana education 
facilities, and testing and research on marijuana and marijuana 
products grown or produced by a patient or caregiver on behalf of a 
patient, upon verification of registration.  No state -approved 
medical marijuana testin g facility shall operate unless a medical 
laboratory director is on site during operational hours. 
H.  A laboratory applicant shall comply with the application 
requirements of this section and shall submit such other information 
as required for a medical m arijuana business applicant, in addition   
 
HB2660 HFLR 	Page 8 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
to any information the Authority may request for initial approval 
and periodic evaluations during the approval period. 
I.  A medical marijuana testing laboratory may accept samples of 
medical marijuana, medical mari juana concentrate or medical 
marijuana product from a medical marijuana business for testing and 
research purposes only, which purposes may include the provision of 
testing services for samples submitted by a medical marijuana 
business for product developm ent.  The Department may require a 
medical marijuana business to submit a sample of medical marijuana, 
medical marijuana concentrate or medical marijuana product to a 
medical marijuana testing laboratory upon demand. 
J.  A medical marijuana testing laborat ory may accept samples of 
medical marijuana, medical marijuana concentrate or medical 
marijuana product from an individual person for testing only under 
the following conditions: 
1.  The individual person is a patient or caregiver pursuant to 
this act or is a participant in an approved clinical or 
observational study conducted by a research facility; and 
2.  The medical marijuana testing laboratory shall require the 
patient or caregiver to produce a valid patient license and current 
and valid photo identifi cation. 
K.  A medical marijuana testing laboratory may transfer samples 
to another medical marijuana testing laboratory for testing.  All 
laboratory reports provided to or by a medical marijuana business or   
 
HB2660 HFLR 	Page 9 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
to a patient or caregiver shall identify the medi cal marijuana 
testing laboratory that actually conducted the test. 
L.  A medical marijuana testing laboratory may utilize a 
licensed medical marijuana transporter to transport samples of 
medical marijuana, medical marijuana concentrate and medical 
marijuana product for testing, in accordance with this act and the 
rules adopted pursuant thereto, between the originating medical 
marijuana business requesting testing services and the destination 
laboratory performing testing services. 
M.  The medical marijuana testing laboratory shall establish 
policies to prevent the existence of or appearance of undue 
commercial, financial or other influences that may diminish the 
competency, impartiality and integrity of the testing processes or 
results of the laboratory, or that may diminish public confidence in 
the competency, impartiality and integrity of the testing processes 
or results of the laboratory.  At a minimum, employees, owners or 
agents of a medical marijuana testing laboratory who participate in 
any aspect of the analysis and results of a sample are prohibited 
from improperly influencing the testing process, improperly 
manipulating data, or improperly benefiting from any ongoing 
financial, employment, personal or business relationship with the 
medical marijuana business that provided the sample.   
 
HB2660 HFLR 	Page 10 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
N.  The Department, pursuant to rules promulgated by the State 
Commissioner of Health, shall develop standards, policies and 
procedures as necessary for: 
1.  The cleanliness and orderliness of a laboratory premises and 
the location of the laboratory in a secure location, and inspection, 
cleaning and maintenance of any equipment or utensils used for the 
analysis of test samples; 
2.  Testing procedures, testing standards for cannabinoid and 
terpenoid potency and safe levels of contaminants, and remediation 
procedures; 
3.  Controlled access areas for storage of medical marijuana and 
medical marijuana product test samples, waste and reference 
standards; 
4.  Records to be retained and computer systems to be utilized 
by the laboratory; 
5.  The possession, storage and use by the laboratory of 
reagents, solutions and reference standards; 
6.  A certificate of analysis (COA) for each lot of reference 
standard; 
7.  The transport and disposal of unused marijuana, marijuana 
products and waste; 
8.  The mandatory use by a laboratory of an inventory tracking 
system to ensure all test batches or samples containing medical 
marijuana, medical marijuana concentrate or medical marijuana   
 
HB2660 HFLR 	Page 11 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
products are identified and tracked from the point they are 
transferred from a medical marijuana business, a patient or a 
caregiver through the point of transfer, destruction or disposal.  
The inventory tracking system reporting shall include the results of 
any tests that are conducted on medical marijuana, medical marijuana 
concentrate or medical marijuana product; 
9.  Standards of performance; 
10.  The employment of laboratory personnel; 
11.  A written standard operating procedure manual to be 
maintained and updated by the laboratory; 
12.  The successful participa tion in a Department -approved 
proficiency testing program for each testing category listed in this 
section, in order to obtain and maintain certification; 
13.  The establishment of and adherence to a quality assurance 
and quality control program to ensure sufficient monitoring of 
laboratory processes and quality of results reported; 
14.  The establishment by the laboratory of a system to document 
the complete chain of custody for samples from receipt through 
disposal; 
15.  The establishment by the laborator y of a system to retain 
and maintain all required records, including business records, and 
processes to ensure results are reported in a timely and accurate 
manner; and   
 
HB2660 HFLR 	Page 12 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
16.  Any other aspect of laboratory testing of medical marijuana 
or medical marijuana p roduct deemed necessary by the Department. 
O.  A medical marijuana testing laboratory shall promptly 
provide the Department or designee of the Department access to a 
report of a test and any underlying data that is conducted on a 
sample at the request of a medical marijuana business or qualified 
patient.  A medical marijuana testing laboratory shall also provide 
access to the Department or designee of the Department to laboratory 
premises and to any material or information requested by the 
Department to determine compliance with the requirements of this 
section. 
P.  A medical marijuana testing laboratory shall retain all 
results of laboratory tests conducted on marijuana or products for a 
period of at least two (2) years and shall make them available to 
the Department upon request. 
Q.  A medical marijuana testing laboratory shall test samples 
from each harvest batch or product batch, as appropriate, of medical 
marijuana, medical marijuana concentrate and medical marijuana 
product for each of the following cat egories of testing, consistent 
with standards developed by the Commissioner: 
1.  Microbials; 
2.  Mycotoxins; 
3.  Residual solvents; 
4.  Pesticides;   
 
HB2660 HFLR 	Page 13 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
5.  Tetrahydrocannabinol (THC) and other cannabinoid potency; 
6.  Terpenoid potency; and 
7.  Heavy metals. 
R.  A test batch shall not exceed ten (10) pounds of usable 
marijuana or medical marijuana product, as appropriate.  A grower 
shall separate each harvest lot of usable marijuana into harvest 
batches containing no more than ten (10) twenty-five (25) pounds.  A 
processor shall separate each medical marijuana production lot into 
production batches containing no more than ten (10) pounds four (4) 
liters of distillate and for final products, the Oklahoma Medical 
Marijuana Authority shall be authorized to promulga te rules on final 
products as necessary.  Provided, however, the Authority shall not 
require testing of final products more often than every two hundred 
(200) grams of THC, unless the batch size processed is less than two 
hundred (200) grams of THC.  As us ed in this subsection, "final 
products" shall include, but not be limited to, cookies, brownies, 
candies, gummies and chocolates . 
S.  Medical marijuana testing laboratory licensure shall be 
contingent upon successful on -site inspection, successful 
participation in proficiency testing and ongoing compliance with the 
applicable requirements in this section. 
T.  A medical marijuana testing laboratory shall be inspected 
prior to initial licensure and annually thereafter by an inspector 
approved by the Authority .   
 
HB2660 HFLR 	Page 14 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
U.  Beginning on a date determined by the Commissioner, not 
later than January 1, 2020, medical marijuana testing laboratory 
licensure shall be contingent upon accreditation by the NELAC 
Institute (TNI), ANSI/ASQ National Accreditation Board or another 
accrediting body approved by the Commissioner, and any applicable 
standards as determined by the Department. 
V.  A commercial grower shall not transfer or sell medical 
marijuana and a processor shall not transfer, sell or process into a 
concentrate or produ ct any medical marijuana, medical marijuana 
concentrate or medical marijuana product unless samples from each 
harvest batch or production batch from which that medical marijuana, 
medical marijuana concentrate or medical marijuana product was 
derived has been tested by a medical marijuana testing facility for 
contaminants and passed all contaminant tests required by this act. 
SECTION 3.  This act shall become effective November 1, 2021. 
 
COMMITTEE REPORT BY: COMMITTEE ON ALCOHOL, TOBACCO AND CONTROLLED 
SUBSTANCES, dated 03/01/2021 - DO PASS, As Amended.